|
AVBP Arrivent Biopharma Inc 1868279 |
| Balance Sheet |
|
Current Assets
|
226,979,000 |
|
Assets
|
274,942,000 |
|
Current Liabilities
|
17,274,000 |
|
Liabilities
|
17,288,000 |
|
Equity
|
257,654,000 |
|
Shares Out
|
33,586,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-70,212,000 |
|
Investing Cash Flow
|
-192,465,000 |
| Market Analysis |
Market Cap
|
825,541,173 |
|
Price
|
19.83 |
|
BVPS
|
7.67 |
|
PB
|
2.55 |
|
EPS
|
-2.46 |
|
PS
|
10.71 |
|
FCF
|
-262,677,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AVBP documents filed with the SEC.
AVBP Filings
Clear
